Sapphire Infusion Pump 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Hospira Pty Limited 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2015-RN-00624-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2015-07-16
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
  • 원인
    Q core (the sapphire infusion pump original manufacturer) has received complaints from customers that when using the epidural mode with patient bolus, the amount of medication delivered may be greater than programmed. in the sapphire pump, as in all infusion systems, external factors may cause fluctuations in flow rate accuracy. investigation of these complaints determined that the deviation observed is exclusively related to the use of catheters with a gauge smaller than that used for the sapphire pump flow accuracy calibration. no patient injuries or deaths have been reported as a result of this issue.
  • 조치
    To address this issue, Q Core Medical is providing an addendum to the User Manual to assist customers in (i) identifying whether the catheter utilized may cause over-delivery, (ii) better understanding the effect of back pressure and catheter size on the accuracy of the delivered volume, (iii) translating the catheter’s back pressure to the degree of flow deviation that can be expected, and (iv) contacting Hospira Representative to determine if and to what extent specific catheter/pump combinations are susceptible to over-delivery. Future versions of the User Manual will incorporate the information contained in the addendum. This action has been closed-out on 30/08/2016.

Device

  • 모델명 / 제조번호(시리얼번호)
    Sapphire Infusion PumpHospira List Number: 163113601/163123601Q Core Number (on pump): 15031-000-0001 /15032-000-0001ARTG Number: 201499
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DHTGA